Detalhe da pesquisa
1.
Assessing thyroid cancer risk using polygenic risk scores.
Proc Natl Acad Sci U S A
; 117(11): 5997-6002, 2020 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32132206
2.
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study.
Lancet Oncol
; 23(12): 1558-1570, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36400106
3.
Automatic Change Detection System over Unmanned Aerial Vehicle Video Sequences Based on Convolutional Neural Networks.
Sensors (Basel)
; 19(20)2019 Oct 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31623134
4.
Insertion of an SVA-E retrotransposon into the CASP8 gene is associated with protection against prostate cancer.
Hum Mol Genet
; 25(5): 1008-18, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26740556
5.
Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.
Hum Mol Genet
; 23(11): 3045-53, 2014 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24403052
6.
Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies.
Oncology (Williston Park)
; 30(12): 1063-70, 2016 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27987198
7.
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.
Nat Genet
; 39(7): 865-9, 2007 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-17529974
8.
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.
Nat Genet
; 39(5): 631-7, 2007 May.
Artigo
Inglês
| MEDLINE | ID: mdl-17401366
9.
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.
Nature
; 452(7187): 638-642, 2008 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-18385739
10.
Natural and orthogonal interaction framework for modeling gene-environment interactions with application to lung cancer.
Hum Hered
; 73(4): 185-94, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22889990
11.
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
Clin Cancer Res
; 29(24): 5021-5030, 2023 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37363965
12.
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
NPJ Breast Cancer
; 9(1): 41, 2023 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37210417
13.
Triple-negative breast cancer in the elderly.
Breast J
; 23(6): 627-629, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29112794
14.
Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer.
Oncologist
; 16(8): 1092-100, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21572124
15.
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.
Cancer Immunol Immunother
; 59(1): 113-24, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19562340
16.
Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study.
Clin Cancer Res
; 15(1): 307-14, 2009 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19118059
17.
GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer.
Nat Commun
; 11(1): 3981, 2020 08 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32769997
18.
A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.
Clin Breast Cancer
; 8(3): 264-8, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-18650157
19.
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Cancer Chemother Pharmacol
; 62(2): 253-61, 2008 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-17901953
20.
[Detection of specific T cells for 264-272 and 149-157 peptides of p53 protein in peripheral blood of patients with breast cancer]. / Detección de linfocitos T citotóxicos contra los epítopos 264-272 y 149-157 de la proteína p53 en sangre periférica de pacientes con cáncer de mama.
Med Clin (Barc)
; 131(18): 685-8, 2008 Nov 22.
Artigo
Espanhol
| MEDLINE | ID: mdl-19087825